News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Labcyte Inc. Commends Early Success Of Collaborator, The Institute For Molecular Medicine Finland, For Personalized Leukemia Treatment Method



12/17/2013 9:54:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SUNNYVALE, Calif. & HELSINKI--(BUSINESS WIRE)--Just eight months after announcing a collaboration between Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM), the partnership has already led to a groundbreaking method for personalized treatment of patients with adult acute myeloid leukemia (AML).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES